Mitsuo Hori

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 12, 2022
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial.

Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki

Pageof 1

Frequent Collaborators

1 joint publications

Meletios A Dimopoulos

1 joint publications

Dominik Dytfeld

1 joint publications

Philippe Moreau

1 joint publications

Xavier Leleu